Risk Factors for 30-Day Mortality in Patients with Bacteremic Pneumonia Caused by Escherichia coli and Klebsiella pneumoniae: A Retrospective Study

References

• Jackson P, Muyanja SZ, Siddharthan T. Health equity and respiratory diseases in low- and middle-income countries. Clin Chest Med. 2023;44(3):623–634. doi:10.1016/j.ccm.2023.03.015
   PubMed Web of Science ®Google Scholar
• Kyu HH, Vongpradith A, Sirota SB, et al. Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the global burden of disease study 2019. Lancet Infect Dis. 2022;22(11):1626–1647. doi:10.1016/s1473-3099(22)00510-2
   PubMed Web of Science ®Google Scholar
• Guillamet CV, Vazquez R, Noe J, Micek ST, Kollef MH. A cohort study of bacteremic pneumonia: the importance of antibiotic resistance and appropriate initial therapy? Medicine. 2016;95(35):e4708. doi:10.1097/md.0000000000004708
   PubMed Web of Science ®Google Scholar
• Assefa M. Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns. Pneumonia. 2022;14(1):4. doi:10.1186/s41479-022-00096-z
   Web of Science ®Google Scholar
• Bassetti M, Magnè F, Giacobbe DR, Bini L, Vena A. New antibiotics for Gram-negative pneumonia. Europ Respirat Rev. 2022;31(166):220119. doi:10.1183/16000617.0119-2022
   PubMed Web of Science ®Google Scholar
• John TM, Deshpande A, Brizendine K, Yu PC, Rothberg MB. Epidemiology and outcomes of community-acquired Escherichia coli pneumonia. Open Forum Infect Diseases. 2022;9(1):ofab597. doi:10.1093/ofid/ofab597
   PubMed Web of Science ®Google Scholar
• Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. doi:10.1164/rccm.201908-1581ST
   PubMed Web of Science ®Google Scholar
• Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious diseases society of America 2022 guidance on the treatment of extended-spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clinl Infect Dis. 2022;75(2):187–212. doi:10.1093/cid/ciac268
   PubMed Web of Science ®Google Scholar
• Gao CA, Morales-Nebreda L, Pickens CI. Gearing up for battle: harnessing adaptive T cell immunity against gram-negative pneumonia. Front Cell Infect Microbiol. 2022;12:934671. doi:10.3389/fcimb.2022.934671
   PubMed Web of Science ®Google Scholar
• Cheng WL, Hsueh PR, Lee CC, et al. Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: appropriateness of empirical treatment matters. J Microbiol Immunol Infect. 2016;49(2):208–215. doi:10.1016/j.jmii.2014.05.003
   PubMedGoogle Scholar
• Chang D, Sharma L, Dela Cruz CS, Zhang D. Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Front Microbiol. 2021;12:750662. doi:10.3389/fmicb.2021.750662
   PubMed Web of Science ®Google Scholar
• Fei F, J Siegert R, Zhang X, Gao W, Koffman J. Symptom clusters, associated factors and health-related quality of life in patients with chronic obstructive pulmonary disease: a structural equation modelling analysis. J Clin Nurs. 2023;32(1–2):298–310. doi:10.1111/jocn.16234
   PubMed Web of Science ®Google Scholar
• Chlamydas S, Markouli M, Strepkos D, Piperi C. Epigenetic mechanisms regulate sex-specific bias in disease manifestations. J Molecul Med. 2022;100(8):1111–1123. doi:10.1007/s00109-022-02227-x
   PubMed Web of Science ®Google Scholar
• Raymond DP, Pelletier SJ, Crabtree TD, Gleason TG, Pruett TL, Sawyer RG. Impact of bloodstream infection on outcomes among infected surgical inpatients. Annals of Surgery. 2001;233(4):549–555. doi:10.1097/00000658-200104000-00011
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Gutiérrez B, Rodríguez-Baño J. Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients. Clin Microbiol Infect. 2019;25(8):932–942. doi:10.1016/j.cmi.2019.03.030
   PubMed Web of Science ®Google Scholar
• Parker JK, Gu R, Estrera GA, et al. Carbapenem-Resistant and ESBL-producing enterobacterales emerging in central Texas. Infect Drug Resist. 2023;16:1249–1261. doi:10.2147/idr.S403448
   PubMedGoogle Scholar
• Chen IR, Lin SN, Wu XN, Chou SH, Wang FD, Lin YT. Clinical and microbiological characteristics of bacteremic pneumonia caused by Klebsiella pneumoniae. Front Cell Infect Microbiol. 2022;12:903682. doi:10.3389/fcimb.2022.903682
   PubMed Web of Science ®Google Scholar
• Kang CI, Song JH, Kim SH, et al. Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia. J Infect. 2013;66(1):34–40. doi:10.1016/j.jinf.2012.08.011
   PubMed Web of Science ®Google Scholar
• Poutsiaka DD, Davidson LE, Kahn KL, Bates DW, Snydman DR, Hibberd PL. Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis. Scand J Infect Dis. 2009;41(6–7):469–479. doi:10.1080/00365540902962756
   PubMed Web of Science ®Google Scholar
• Di Pasquale MF, Sotgiu G, Gramegna A, et al. Prevalence and etiology of community-acquired pneumonia in immunocompromised patients. Clinl Infect Dis. 2019;68(9):1482–1493. doi:10.1093/cid/ciy723
   PubMed Web of Science ®Google Scholar
• Henderson H, Luterbach CL, Cober E, et al. The Pitt bacteremia score predicts mortality in nonbacteremic infections. Clinl Infect Dis. 2020;70(9):1826–1833. doi:10.1093/cid/ciz528
   PubMed Web of Science ®Google Scholar
• Kim YC, Choi H, Kim YA, et al. Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections. PLoS One. 2023;18(1):e0280196. doi:10.1371/journal.pone.0280196
   PubMed Web of Science ®Google Scholar
• Su C, Tsai IT, Lai CH, Lin KH, Chen CC, Hsu YC. Prediction of 30-day mortality using the quick Pitt bacteremia score in hospitalized patients with Klebsiella pneumoniae infection. Infect Drug Resist. 2023;16:4807–4815. doi:10.2147/idr.S420569
   PubMed Web of Science ®Google Scholar
• Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. New Engl J Med. 2019;380(2):171–176. doi:10.1056/NEJMra1808137
   PubMed Web of Science ®Google Scholar
• Rögnvaldsson KG, Bjarnason A, Kristinsson K, et al. Acetylsalicylic acid use is associated with improved survival in bacteremic pneumococcal pneumonia: a long-term nationwide study. J Internal Med. 2022;292(2):321–332. doi:10.1111/joim.13485
   Google Scholar
• Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax. 2007;62(3):253–259. doi:10.1136/thx.2006.067371
   PubMed Web of Science ®Google Scholar
• Wellbelove Z, Walsh C, Perinpanathan T, Lillie P, Barlow G. Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients. J Infect. 2021;82(3):414–451. doi:10.1016/j.jinf.2020.10.015
   PubMed Web of Science ®Google Scholar
• Spindler C, Ortqvist A. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. Europ Resp J. 2006;28(4):816–823. doi:10.1183/09031936.06.00144605
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar